The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials
Open accessAbstract
Background: Many patients with borderline personality disorder receive pharmacological treatment, but there is uncertainty about the usefulness of such therapies. Aims: To evaluate the evidence of effectiveness of pharmacotherapy in treating different facets of the psychopathology of borderline personality disorder. Method: A Cochrane Collaboration systematic review and meta-analysis of randomised comparisons of drug v. placebo, drug v. drug, or single drug v. combined drug treatment in adult patients with borderline personality disorder was conducted. Primary outcomes were overall disorder severity as well as specific core symptoms. Secondary outcomes comprised associated psychiatric pathology and drug tolerability. Results: Twenty-seven trials were included in which first- and second-generation antipsychotics, mood stabilisers, antidepressants and omega-3 fatty acids were tested. Most beneficial effects were found for the mood stabilisers topiramate, lamotrigine and valproate semisodium, and the second-generation antipsychotics aripiprazole and olanzapine. However, the robustness of findings is low, since they are based mostly on single, small studies. Selective serotonin reuptake inhibitors so far lack high-level evidence of effectiveness. Conclusions: The current evidence from randomised controlled trials suggests that drug treatment, especially with mood stabilisers and second-generation antipsychotics, may be effective for treating a number of core symptoms and associated psychopathology, but the evidence does not currently support effectiveness for overall severity of borderline personality disorder. Pharmacotherapy should therefore be targeted at specific symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., Smith, S. M., Dawson, D. S., Pulay, A. J., Pickering, R. P., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0404 · Cited by 1,618
Borderline personality disorder
Lieb, K., Zanarini, M. C., Schmahl, C., Linehan, M. M., & Bohus, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16770-6 · Cited by 1,369
Self-citationThe Prevalence of Personality Disorders in a Community Sample
Torgersen, S., Kringlen, E., & Cramer, V. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.590 · Cited by 1,313
Full publication of results initially presented in abstracts.
Scherer, R. W., Langenberg, P., & von Elm, E. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000005.pub3 · Cited by 997
Prevalence and correlates of personality disorder in Great Britain
Coid, J., Yang, M., Tyrer, P., Roberts, A., & Ullrich, S. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.5.423 · Cited by 901
Skodol, A. E., Gunderson, J. G., McGlashan, T. H., Dyck, I. R., Stout, R. L., Bender, D. S., Grilo, C. M., Shea, M. T., Zanarini, M. C., Morey, L. C., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.276 · Cited by 708
Zanarini, M. C., Frankenburg, F. R., Hennen, J., Reich, D. B., & Silk, K. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2108 · Cited by 525
Black, D. W., Blum, N., Pfohl, B., & Hale, N. (2004) · Journal of Personality Disorders · doi:10.1521/pedi.18.3.226.35445 · Cited by 522
Oldham, J. M. (2005) · Focus · doi:10.1176/foc.3.3.396 · Cited by 429
Zanarini, M. C. (2003) · Journal of Personality Disorders · doi:10.1521/pedi.17.3.233.22147 · Cited by 413
Zanarini, M. C., & Frankenburg, F. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.167 · Cited by 352
Empirical Evidence and Psychotherapy: A Growing Scientific Base
GABBARD, G. O. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.1 · Cited by 348
Practice Guideline for the Treatment of Patients With Borderline Personality Disorder
(2007) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.54853 · Cited by 345
Reliability and Validity of the Borderline Personality Disorder Severity Index
Arntz, A., van den Hoorn, M., Cornelis, J., Verheul, R., van den Bosch, W. M. C., & de Bie, A. J. H. T. (2003) · Journal of Personality Disorders · doi:10.1521/pedi.17.1.45.24053 · Cited by 305
Pharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302
Self-citationZanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0105 · Cited by 285
Effect of Fluoxetine on Anger in Symptomatic Volunteers With Borderline Personality Disorder
Salzman, C., Wolfson, A. N., Schatzberg, A., Looper, J., Henke, R., Albanese, M., Schwartz, J., & Miyawaki, E. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00005 · Cited by 281
Pulay, A. J., Stinson, F. S., Dawson, D. A., Goldstein, R. B., Chou, S. P., Huang, B., Saha, T. D., Smith, S. M., Pickering, R. P., Ruan, W. J., et al. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08m00679 · Cited by 260
Childhood Abuse as a Risk Factor For Suicidal Behavior in Borderline Personality Disorder
Soloff, P. H., Lynch, K. G., & Kelly, T. M. (2002) · Journal of Personality Disorders · doi:10.1521/pedi.16.3.201.22542 · Cited by 256
Zanarini, M. C., & Frankenburg, F. R. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1103 · Cited by 251
Borderline and Schizotypal Personality Disorders Treated With Low-Dose Thiothixene vs Placebo
Goldberg, S. C. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070070009 · Cited by 248
Nickel, M. K., Muehlbacher, M., Nickel, C., Kettler, C., Gil, F. P., Bachler, E., Buschmann, W., Rother, N., Fartacek, R., Egger, C., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.833 · Cited by 236
Efficacy of Phenelzine and Haloperidol in Borderline Personality Disorder
Soloff, P. H. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170055007 · Cited by 235
Soler, J., Pascual, J. C., Campins, J., Barrachina, J., Puigdemont, D., Alvarez, E., & Pérez, V. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1221 · Cited by 224
Rinne, T., van den Brink, W., Wouters, L., & van Dyck, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2048 · Cited by 223
Frankenburg, F. R., & Zanarini, M. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0511 · Cited by 221
Hollander, E., Allen, A., Lopez, R. P., Bienstock, C. A., Grossman, R., Siever, L. J., Merkatz, L., & Stein, D. J. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0311 · Cited by 206
The prevalence of personality disorder among UK primary care attenders
Moran, P., Jenkins, R., Tylee, A., Blizard, R., & Mann, A. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.102001052.x · Cited by 200
Hallahan, B., Hibbeln, J. R., Davis, J. M., & Garland, M. R. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.022707 · Cited by 191
Tritt, K., Nickel, C., Lahmann, C., Leiberich, P. K., Rother, W. K., Loew, T. H., & Nickel, M. K. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051540 · Cited by 189
Amitriptyline versus Haloperidol in Borderlines: Final Outcomes and Predictors of Response
SOLOFF, P. H., GEORGE, A., NATHAN, R. S., SCHULZ, P. M., CORNELIUS, J. R., HERRING, J., & PEREL, J. M. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198908000-00002 · Cited by 178
Nickel, M. K., Nickel, C., Mitterlehner, F. O., Tritt, K., Lahmann, C., Leiberich, P. K., Rother, W. K., & Loew, T. H. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1112 · Cited by 177
Nickel, M. K., Nickel, C., Kaplan, P., Lahmann, C., Mühlbacher, M., Tritt, K., Krawczyk, J., Leiberich, P. K., Rother, W. K., & Loew, T. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.044 · Cited by 177
Zanarini, M. C., Frankenburg, F. R., & Parachini, E. A. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0704 · Cited by 174
Olanzapine Versus Placebo in the Treatment of Borderline Personality Disorder
Bogenschutz, M. P., & Nurnberg, H. G. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0118 · Cited by 168
Herpertz, S. C., Zanarini, M., Schulz, C. S., Siever, L., Lieb, K., Möller, H.-J., Wfsbp Task Force on Personality Dis, Herpertz, S. C., Zanarini, M., Schulz, C. S., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701685224 · Cited by 164
Self-citationSimpson, E. B., Yen, S., Costello, E., Rosen, K., Begin, A., Pistorello, J., & Pearlstein, T. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0314 · Cited by 156
Pharmacological interventions for people with borderline personality disorder
Binks, C., Fenton, M., McCarthy, L., Lee, T., Adams, C. E., & Duggan, C. F. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653 · Cited by 150
A trial of carbamazepine in borderline personality disorder
la Fuente, J. D., & Lotstra, F. (1994) · European Neuropsychopharmacology · doi:10.1016/0924-977x(94)90296-8 · Cited by 128
Loew, T. H., Nickel, M. K., Muehlbacher, M., Kaplan, P., Nickel, C., Kettler, C., Fartacek, R., Lahmann, C., Buschmann, W., Tritt, K., et al. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000195113.61291.48 · Cited by 127
Linehan, M. M., McDavid, J. D., Brown, M. Z., Sayrs, J. H. R., & Gallop, R. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0617 · Cited by 113
Response of borderline patients to loxapine and chlorpromazine.
Leone, N. (1982) · PubMed · Cited by 76
Ziprasidone in the Treatment of Borderline Personality Disorder
Pascual, J. C., Soler, J., Puigdemont, D., Pérez‐Egea, R., Tiana, T., Álvarez, E., & Pérez, V. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0412 · Cited by 75
Pérez, V., Barrachina, J., Soler, J., Pascual, J. C., Campins, M. J., Puigdemont, D., & Álvarez, E. (2007) · PubMed · Cited by 70
Abraham, P. F., & Calabrese, J. R. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.024 · Cited by 57
Mianserin in the Prophylaxis of Suicidal Behaviour: a Double Blind Placebo Controlled Trial
Montgomery, D., Montgomery, S., & Roy, D. H. (1983) · Elsevier eBooks · doi:10.1016/b978-0-08-027080-7.50130-0 · Cited by 7
Cited by
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Psychological therapies for people with borderline personality disorder.
Stoffers-Winterling, J. M., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005652.pub2 · Cited by 895
Self-citationBorderline personality disorder
Leichsenring, F., Leibing, E., Kruse, J., New, A. S., & Leweke, F. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61422-5 · Cited by 895
Davies, E. B., Morriss, R., & Glazebrook, C. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3142 · Cited by 499
Borderline personality disorder
Gunderson, J. G., Herpertz, S. C., Skodol, A. E., Torgersen, S., & Zanarini, M. C. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.29 · Cited by 470
Metadata
- Authors
- Lieb, K., Völlm, B., Rücker, G., Timmer, A., & Stoffers, J. M.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2010-01
- Volume
- 196
- Issue
- 1
- Pages
- 4-12
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2145076401
- Cited by
- 410
- References
- 53
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.